Clinical decision tools are needed to identify HIV-positive patients at high risk for poor outcomes after initiation of antiretroviral therapy

Margaret McNairy and colleagues highlight the need for clinical decision tools to help identify HIV patients who would benefit from tailored services to avoid poor outcomes such as death and loss to follow-up.

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	PLoS medicine 2017-04, Vol.14 (4), p.e1002278-e1002278
Hauptverfasser:	McNairy, Margaret L, Abrams, Elaine J, Rabkin, Miriam, El-Sadr, Wafaa M
Format:	Artikel
Sprache:	eng
Schlagworte:	Abbreviations Acquired immune deficiency syndrome Adult AIDS Analysis Anti-HIV Agents - therapeutic use Antiretroviral agents Antiretroviral drugs Antiretroviral therapy Antiretroviral Therapy, Highly Active Biology and Life Sciences Care and treatment Child Children Decision making Decision Support Techniques Female Health aspects Health risks Highly active antiretroviral therapy HIV HIV infections HIV Infections - diagnosis HIV Infections - drug therapy HIV Infections - mortality HIV-1 Human immunodeficiency virus Humans Mail Male Medicine and Health Sciences Mortality Patient compliance People and Places Policy Forum Prognosis Public health Research Design Risk Factors Social Sciences Treatment Outcome Tuberculosis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Margaret McNairy and colleagues highlight the need for clinical decision tools to help identify HIV patients who would benefit from tailored services to avoid poor outcomes such as death and loss to follow-up.
ISSN:	1549-1676 1549-1277 1549-1676
DOI:	10.1371/journal.pmed.1002278